Two recent studies considered whether initiation of second-line therapies in patients already taking metformin for type 2 diabetes occurs too soon or too late.
One recent study reported on the development and validation of an artificial intelligence algorithm for detecting diabetic retinopathy, while another tested such technology in primary care.
Two recent studies looked at the effects of diabetes on the brain, one focusing on mild cognitive impairment and the other on brain imaging findings.
Recent studies looked at how often patients underuse insulin due to cost, whether Supplemental Nutrition Assistance Program participation reduces cost-related nonadherence, and how high deductibles affect the timing of care for macrovascular
Older patients with diabetes were the focus of several recent studies, including one that looked at associations between glycemic control and mortality and two that compared second-line medication options.
Studies published in July looked at factors and conditions associated with variation in glycemic control between clinic visits, including diabetes treatment intensity and Alzheimer's disease.
Two studies compared heart failure rates in patients with and without type 2 diabetes, while a third looked at the risk of heart failure associated with various classes of glucose-lowering drugs.
Recent studies looked at prevalence of diagnosed diabetes in the U.S.; trends in hospitalization for diabetic ketoacidosis; and the prevalence of obesity, metabolic syndrome, and diabetes.
Mortality and cardiovascular complications from diabetes have gone down, but incidence rates among youth are up, according to recent studies of Swedish and American patients, respectively.
Recent studies looked at diabetic retinopathy's associations with age-related macular degeneration, chronic kidney disease, and different classes of diabetes drugs.